246 related articles for article (PubMed ID: 29653559)
21. Identification of diagnostic utility and molecular mechanisms of circulating miR-551b-5p in gastric cancer.
Jiang X; Jiang M; Xu M; Xu J; Li Y
Pathol Res Pract; 2019 May; 215(5):900-904. PubMed ID: 30732916
[TBL] [Abstract][Full Text] [Related]
22. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
Tsai MM; Wang CS; Tsai CY; Huang CG; Lee KF; Huang HW; Lin YH; Chi HC; Kuo LM; Lu PH; Lin KH
Eur J Cancer; 2016 Sep; 64():137-48. PubMed ID: 27420607
[TBL] [Abstract][Full Text] [Related]
23. Circulating exosomal small RNAs are promising non-invasive diagnostic biomarkers for gastric cancer.
Ge L; Zhang N; Li D; Wu Y; Wang H; Wang J
J Cell Mol Med; 2020 Dec; 24(24):14502-14513. PubMed ID: 33169519
[TBL] [Abstract][Full Text] [Related]
24. The significance of elevated plasma expression of microRNA 106b~25 clusters in gastric cancer.
Li F; Guo Y; Liu J; Zhang R
PLoS One; 2017; 12(5):e0178427. PubMed ID: 28562634
[TBL] [Abstract][Full Text] [Related]
25. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
26. Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer.
Huang Y; Zhu J; Li W; Zhang Z; Xiong P; Wang H; Zhang J
Oncol Rep; 2018 Mar; 39(3):1338-1346. PubMed ID: 29286167
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer.
Su ZX; Zhao J; Rong ZH; Wu YG; Geng WM; Qin CK
Tumour Biol; 2014 Dec; 35(12):12119-25. PubMed ID: 25416437
[TBL] [Abstract][Full Text] [Related]
29. Gastric Juice MicroRNAs as Potential Biomarkers for Screening Gastric Cancer: A Systematic Review.
Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Mercantini P; Balducci G; Cavallini M
Anticancer Res; 2018 Feb; 38(2):613-616. PubMed ID: 29374683
[TBL] [Abstract][Full Text] [Related]
30. A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer.
Ahadi A
Immunogenetics; 2021 Apr; 73(2):155-161. PubMed ID: 33399935
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of circulating microRNAs for gastric cancer in Asian populations: a meta-analysis.
Liu L; Wang S; Cao X; Liu J
Tumour Biol; 2014 Dec; 35(12):11995-2004. PubMed ID: 25159040
[TBL] [Abstract][Full Text] [Related]
32. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
Zhang HP; Sun FB; Li SJ
Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
[TBL] [Abstract][Full Text] [Related]
33. Expression and prognostic value of miR-92a in patients with gastric cancer.
Ren C; Wang W; Han C; Chen H; Fu D; Luo Y; Yao H; Wang D; Ma L; Zhou L; Han D; Shen M
Tumour Biol; 2016 Jul; 37(7):9483-91. PubMed ID: 26790436
[TBL] [Abstract][Full Text] [Related]
34. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer.
Cai H; Yuan Y; Hao YF; Guo TK; Wei X; Zhang YM
Med Oncol; 2013 Mar; 30(1):452. PubMed ID: 23307259
[TBL] [Abstract][Full Text] [Related]
35. A novel urinary microRNA biomarker panel for detecting gastric cancer.
Iwasaki H; Shimura T; Yamada T; Okuda Y; Natsume M; Kitagawa M; Horike SI; Kataoka H
J Gastroenterol; 2019 Dec; 54(12):1061-1069. PubMed ID: 31240436
[TBL] [Abstract][Full Text] [Related]
36. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer.
Zeng W; Zhang S; Yang L; Wei W; Gao J; Guo N; Wu F
BMC Med Genet; 2020 Feb; 21(1):28. PubMed ID: 32041551
[TBL] [Abstract][Full Text] [Related]
37. Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer.
Li Y; Sun H; Guan J; Ji T; Wang X
Yonsei Med J; 2019 Aug; 60(8):720-726. PubMed ID: 31347326
[TBL] [Abstract][Full Text] [Related]
38. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.
Liu H; Zhu L; Liu B; Yang L; Meng X; Zhang W; Ma Y; Xiao H
Cancer Lett; 2012 Mar; 316(2):196-203. PubMed ID: 22169097
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of low miR-144 expression in gastric cancer.
Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
Cancer Biomark; 2017 Dec; 20(4):547-552. PubMed ID: 28800316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]